Aclaris Therapeutics (ACRS) Inventory Average (2018 - 2019)

Aclaris Therapeutics (ACRS) recorded quarterly Inventory Average of $187000.0 in Q3 2019, down 64.07% quarter-over-quarter from $520500.0 in Q2 2019, and down 81.93% on a YoY basis from $1.0 million in Q3 2018.

Aclaris Therapeutics (ACRS) Inventory Average (2018 - 2019) Analysis & Trends

Aclaris Therapeutics' Inventory Average history runs 2 years deep, the most recent figure standing at $187000.0 for Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.59 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.73 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Aclaris Therapeutics 580.93 Mn 580.93 Mn 1.60 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2019 187,000.00
Jun 30, 2019 520,500.00
Mar 31, 2019 823,500.00
Dec 31, 2018 917,500.00
Sep 30, 2018 1.04 Mn